Koashoji Holdings
Basic Information
- Stock Code
- 9273
- Industry
- Wholesale
- Category Detail
- Pharmaceuticals & Medical Products Wholesalers
- Prefecture
- Kanagawa Prefecture
- Establishment Year
- January 2015
- Listing Year
- June 2018
- Official Website
- https://www.koashoji-hd.com/
- TSE Information
- TSE Information
- Yahoo! Finance
- Yahoo! Finance
- Other Companies
- Alfresa Holdings, Hokuyaku Takeyama Holdings, Vital KSK Holdings, Medias, Cosmo Bio, Oki Healthcare Holdings, Solasia Pharma, Otake, Medipal Holdings, Astena Holdings, Toho Holdings, SunNexTa, Suzuken
Overview
Koashoji Holdings is a mid-sized company in the pharmaceutical wholesale industry established in 2015, focusing on the import and sales of active pharmaceutical ingredients and pharmaceutical manufacturing to achieve sustainable medical product supply.
Current Situation
Koashoji Holdings has secured stable sales centered on its pharmaceutical wholesale business in fiscal 2023. Its core operations include importing and selling pharmaceutical APIs and manufacturing medical pharmaceuticals, with efforts underway to expand market share domestically. In this fiercely competitive industry, its rapid supply system and quality control are highly regarded, positioning it against major players like Medipal and Suzuken. The company is emphasizing generic drugs and bio-pharmaceuticals, bolstering R&D. From a sustainability standpoint, it is addressing environmental burden reduction and quality management enhancements. Medium- to long-term strategies include manufacturing capacity expansion and overseas market development. Recently, it raised funds via capital increase to advance pharmaceutical manufacturing technologies.
Trivia
Interesting Facts
- Rapid-growth company that listed on the Tokyo Stock Exchange Mothers just a few years after founding.
- Recognized as a rare mid-sized pharmaceutical trader specializing in API imports.
- Operates on dual pillars of wholesaling and manufacturing with in-house pharmaceutical production lines.
- Handles a wide range from generics to bio-agents.
- Gained high trust from medical institutions through proprietary quality control system.
- Focusing on development of environmentally conscious packaging materials.
- Expanding R&D outsourcing and contract manufacturing (CMO) in recent years.
- Diversifying by providing numerous medical devices and hygiene materials.
- Company name 'Koashoji' signifies core technologies and customer-centric approach.
- Acquired GMP certification from MHLW, ensuring manufacturing quality.
- Collaborates with domestic and international pharmaceutical research institutions for product improvements.
- Diverse pharmaceutical product portfolio despite small scale.
- Gained trust from pharmaceutical companies through quality testing outsourcing.
- Achieves stable supply as a supplier of medical consumables.
- Actively participates in strengthening alliances among mid-sized firms in the industry.
Hidden Connections
- Supports the foundation of Japan's pharmaceutical industry by supplying APIs to pharma ventures.
- Serves as a bridge for some overseas pharmaceutical companies entering the Japanese market.
- Achieved business diversification beyond wholesaling through partnerships in medical devices.
- Participates in recycling promotion projects for packaging materials with environmental NPOs.
- Strengthened manufacturing technology through joint development with generic drug manufacturers.
- Building strategic capital relationships aimed at forming domestic mid-sized pharmaceutical wholesale conglomerates.
- Introduces new synthesis technologies through technical exchanges with university pharmacy labs.
- Contributes to improved public health environments through hygiene material supply to medical institutions.
Future Outlook
Growth Drivers
- Stable growth in domestic pharmaceutical wholesale market
- Expanding demand for generic pharmaceuticals
- Rapid growth in bio-pharmaceutical market
- Expansion of contract manufacturing (CMO) business
- Increasing demand for eco-friendly products and packaging
- Active equipment investments by medical institutions
- Advancement and diversification of R&D technologies
- Acceleration of expansion into overseas pharmaceutical markets
- Rising interest in sustainable medical supplies
- Efficiency improvements through digitalization and automation
- Quality enhancements in response to advanced regulations
- Ongoing demand for stable medical consumables supply
Strategic Goals
- Achieve 50% increase in contract manufacturing sales
- Elevate bio-pharmaceutical manufacturing technology to industry top class
- Reach 60% sales ratio for eco-friendly packaging materials
- Target 30%+ overseas market sales ratio
- Complete digitalization of pharmaceutical supply chain
- Acquire and maintain additional ISO quality certifications
- Establish and operate sustainable logistics systems
- Nationwide rollout of local medical support programs
- Maintain R&D investment ratio above 10%
- Strengthen diversity promotion and talent development
Business Segments
Pharmaceutical API Import and Sales
- Overview
- Imports pharmaceutical raw materials from overseas and stably supplies them to domestic manufacturers.
- Competitiveness
- Rapid supply through extensive overseas procurement networks
- Customers
-
- Domestic pharmaceutical manufacturers
- Generic drug manufacturers
- R&D institutions
- Bio ventures
- Products
-
- High-purity pharmaceutical APIs
- Synthesis intermediates
- Generic-compatible APIs
Medical Pharmaceutical Manufacturing
- Overview
- Manufactures medical pharmaceuticals domestically with thorough quality control.
- Competitiveness
- Advanced bio-pharmaceutical manufacturing technology
- Customers
-
- Medical institutions
- Wholesalers
- Hospitals and clinics
- Pharmaceutical companies
- Products
-
- Medical generic pharmaceuticals
- Bio agents
- Follow-on pharmaceuticals
Medical Devices and Hygiene Materials Supply
- Overview
- Handles supply of essential equipment and materials for medical sites.
- Competitiveness
- Broad product lineup and rapid delivery
- Customers
-
- Hospitals
- Nursing facilities
- Clinics
- Drugstores
- Products
-
- Disposable syringes
- Sterilization materials
- Disinfectants and hygiene materials
Pharmaceutical R&D Reagents and Equipment Sales
- Overview
- Provides essential reagents and testing equipment for pharmaceutical development.
- Competitiveness
- Stable supply of high-purity reagents and high-performance equipment
- Customers
-
- Pharmaceutical company labs
- University research institutions
- Bio companies
- Analysis labs
- Products
-
- Research reagents
- Analysis equipment
- Quality testing equipment
Packaging Materials Manufacturing and Sales
- Overview
- Manufactures and sells pharmaceutical-specific packaging materials.
- Competitiveness
- Product development balancing environmental considerations and safety
- Customers
-
- Pharmaceutical manufacturers
- Pharmaceutical wholesalers
- Processing companies
- Logistics companies
- Products
-
- Pharmaceutical blister packaging
- Eco-friendly packaging materials
- Packaging-related equipment
Logistics and Transportation Services
- Overview
- Provides safe logistics services for pharmaceutical raw materials and products.
- Competitiveness
- Specialized expertise in strict temperature control and delivery
- Customers
-
- Pharmaceutical manufacturers
- Pharmaceutical wholesalers
- Medical facilities
- Research facilities
- Products
-
- Temperature-controlled transport
- Hazardous materials handling
- Warehouse management
Quality Control and Analysis Technology Support
- Overview
- Consulting services for quality assurance in pharmaceutical R&D.
- Competitiveness
- Advanced analysis technology and extensive track record
- Customers
-
- Pharmaceutical companies
- Bio companies
- Research institutions
- Medical institutions
- Products
-
- Quality testing outsourcing
- Formulation development support
- Stability evaluation
Health Foods and Supplements Sales
- Overview
- Expands sales of health supplements for general consumers.
- Competitiveness
- Thorough quality ingredients and safety measures
- Customers
-
- Mail-order businesses
- Drugstores
- Retail stores
- Consumers
- Products
-
- Vitamin preparations
- Functional foods
- Nutritional supplements
Kampo Raw Materials Supply
- Overview
- Supplies a wide range of raw materials for Kampo drug manufacturing.
- Competitiveness
- Strict raw material quality control
- Customers
-
- Kampo drug manufacturers
- Traditional medical facilities
- Health food companies
- Wholesalers
- Products
-
- Plant-derived materials
- Kampo formulation materials
- Traditional herbal medicines
Antibacterial and Disinfectant Supply
- Overview
- Provides infection control products to diverse customer segments.
- Competitiveness
- Proven product development capabilities
- Customers
-
- Medical institutions
- Welfare facilities
- Cleaning services
- Retailers
- Products
-
- Hand disinfectants
- Environmental disinfectants
- Antibacterial sprays
Formulation Development Outsourcing Services
- Overview
- Specializes in technical support and quality evaluation for formulation development.
- Competitiveness
- Advanced technical know-how and proven results
- Customers
-
- Pharmaceutical companies
- Development ventures
- Research institutions
- Quality control organizations
- Products
-
- New formulation development
- Quality evaluation
- Technical consulting
Pharmaceutical Contract Manufacturing (CMO)
- Overview
- Provides contract manufacturing services to pharmaceutical companies.
- Competitiveness
- Flexible production system and quality control
- Customers
-
- Pharmaceutical manufacturers
- Bio companies
- Overseas pharmaceutical companies
- Generic manufacturers
- Products
-
- API manufacturing
- Formulation processing
- Packaging and inspection
Competitive Advantage
Strengths
- High-quality pharmaceutical API import routes
- Diverse pharmaceutical manufacturing technologies
- Strict quality control system
- Rapid logistics network
- Bio-pharmaceutical manufacturing capabilities
- Extensive R&D support experience
- Eco-friendly packaging technology
- Broad customer base
- Stable financial foundation
- High regulatory compliance capabilities
- Flexible contract manufacturing system
- Comprehensive talent development programs
- Strong medical institution network
- Reliable product supply
- Active technology investments
Competitive Advantages
- Excels in building procurement and supply networks covering Japan and abroad
- Unique mid-sized wholesaler with strengths in pharmaceutical manufacturing
- Superior quality control in high-purity API import sales compared to competitors
- Holds advanced manufacturing technologies in bio-pharmaceuticals and generics
- Expanding transactions through multifaceted product offerings to medical institutions
- Covers niche markets with detailed logistics services
- Successful differentiation via early adoption of sustainable packaging materials
- Highly evaluated by pharmaceutical manufacturers for quality assurance and regulatory compliance
- Broad formulation development and outsourcing services support sales expansion
- Customer acquisition from research institutions via latest analyzer introductions
- Focus on R&D enhancement using capital increases
- Possesses many highly skilled engineers through talent development
- Flexible response to diverse pharmaceutical market needs
- High customer trust contributes to new project wins
- Actively pursuing M&A to accelerate growth
Threats
- Intense competition with major pharmaceutical wholesalers
- Risk of international API price fluctuations
- Manufacturing and sales restrictions from regulatory changes
- Intensifying price competition in generic drug market
- Delays in adapting to rapid advances in new pharmaceutical technologies
- Logistics disruptions from infectious disease outbreaks
- Supply instability from overseas procurement sources
- Cost increases from exchange rate fluctuations
- Increased operating costs from stricter environmental regulations
- R&D stagnation due to talent acquisition difficulties
- Market share erosion from new entrants
- Decline in competitive edge from technology leakage risks
Innovations
2024: Introduction of Automated Pharmaceutical Manufacturing Lines
- Overview
- Introduced the latest automation systems in pharmaceutical factories to improve production efficiency.
- Impact
- 20% increase in production capacity, achieved uniform quality
2023: Advancement of Bio-Pharmaceutical Manufacturing Technology
- Overview
- Optimized antibody drug manufacturing processes to improve quality and yield.
- Impact
- 10% reduction in manufacturing costs, enhanced product stability
2022: Development and Introduction of Eco-Friendly Packaging Materials
- Overview
- Developed and commercialized pharmaceutical packaging materials using biodegradable materials.
- Impact
- 30% reduction in environmental impact, improved customer satisfaction
2021: Renewal of Temperature-Controlled Logistics System
- Overview
- Introduced advanced transport and delivery systems minimizing temperature fluctuations.
- Impact
- 20% reduction in quality degradation risks during transport
2020: Enhancement of Generic Pharmaceutical Manufacturing Capacity
- Overview
- Installed new production lines to expand capacity and product lineup.
- Impact
- 15% increase in annual production, expanded customer base
Sustainability
- Promotion of waste reduction programs in manufacturing processes
- CO2 emissions reduction through improved energy efficiency
- Active adoption of eco-friendly packaging materials
- Enhanced safety and quality management to improve pharmaceutical reliability
- Advancing environmental protection activities in collaboration with local communities
- Workplace environment improvements prioritizing employee health and work-life balance
- Introduction of green chemistry in R&D
- Achieving transparent supply chain management
- Thorough corporate compliance and CSR activities
- Strengthening sustainable raw material procurement
- Promoting diversity and inclusion
- Raising environmental awareness through education and enlightenment activities